Format

Send to

Choose Destination
FEBS Lett. 2006 Jul 10;580(16):4000-4. Epub 2006 Jun 22.

Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin.

Author information

1
Institute of Diabetes Research, Academic Hospital Munich-Schwabing, Koelner Platz 1, D-80804 Munich, Germany. Sabine.Hofmann@lrz.uni-muenchen.de

Abstract

Wolfram syndrome is caused by mutations in WFS1 encoding wolframin, a polytopic membrane protein of the endoplasmic reticulum. Here, we investigated the molecular pathomechanisms of four missense and two truncating mutations in WFS1. Expression in COS-7 cells as well as direct analysis of patient cells revealed that WFS1 mutations lead to drastically reduced steady-state levels of wolframin. All mutations resulted in highly unstable proteins which were delivered to proteasomal degradation. No wolframin aggregates were found in patient cells suggesting that Wolfram syndrome is not a disease of protein aggregation. Rather, WFS1 mutations cause loss-of-function by cellular depletion of wolframin.

PMID:
16806192
DOI:
10.1016/j.febslet.2006.06.036
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center